trending Market Intelligence /marketintelligence/en/news-insights/trending/a15LekC9CPqK0Flo6aK6zQ2 content esgSubNav
In This List

DBV Technologies chief medical officer resigns; interim named

Blog

Gauging Supply Chain Risk In Volatile Times

Blog

Insight Weekly: Banks' efficiency push; vacuuming carbon; Big Pharma diversity goals

Blog

The Future of Risk Management Digitization in Credit Risk Management

Blog

Climate Credit Analytics: Diving into the model


DBV Technologies chief medical officer resigns; interim named

DBV Technologies S.A. said Lucia Septien-Velez is leaving her role as the company's chief medical officer to pursue other opportunities.

Hugh Sampson, DBV's chief scientific officer since June 2015, will now also serve as interim chief medical officer.

Paris-based DBV Technologies is developing a proprietary technology platform for use in immunotherapy.